Company: PTPI
Filing Date: 2025-02-13
Form Type: S-1/A
Source: 0001410578-25-000122
Chunk: 297

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-13
Form: S-1/A
Chunk 297
---
.LAB* |     | Inline XBRL Taxonomy Extension Labels Linkbase Document                                                                                                               |
| 101.PRE* |     | Inline XBRL Taxonomy Extension Presentation Linkbase Document                                                                                                         |
| 107*     |     | Filing Fee Table.                                                                                                                                                     |

| * | Filed herewith. |

| ** | Previously filed. |

| ∞ | Certain of the schedules (and similar attachments) to these exhibits have been omitted in accordance with Regulation S-K Item 601(a)(5) of Regulation S-K under the Securities Act of 1933, as amended, because they do not contain information material to an investment or voting decision and that information is not otherwise disclosed in the exhibit or the disclosure document. The registrant hereby agrees to furnish a copy of all omitted schedules (or similar attachments) to the SEC upon its request. |

+Portions of these exhibits have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as amended, because they are both (i) not material and (ii) the type that the registrant treats as private or confidential. A copy of the omitted portions will be furnished to the SEC upon its request. †Management contract or compensatory plan or arrangement.

II-7

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in New York, New York, on the 13th day of February 2025.

| PETROS PHARMACEUTICALS, INC. |                                        |
| By:                          | /s/ Fady Boctor                        |
|                              | Fady Boctor                            |
|                              | President and Chief Commercial Officer |

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature           
 /s/ Fady Boctor     |     | Title                                                         
 President and Chief Commercial Officer                        |   | Date              
 February 13, 2025 |
|:--------------------|:----|:--------------------------------------------------------------|:--|:------------------|
| Fady Boctor         |     | -Principal Executive Officer                                  |   | ​                 |
|                     |     | ​                                                             | ​ | ​                 |
| *                   |     | Vice President of Finance